Salehi, B.; Selamoglu, Z.; S. Mileski, K.; Pezzani, R.; Redaelli, M.; C. Cho, W.; Kobarfard, F.; Rajabi, S.; Martorell, M.; Kumar, P.;
et al. Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules 2019, 9, 773.
https://doi.org/10.3390/biom9120773
AMA Style
Salehi B, Selamoglu Z, S. Mileski K, Pezzani R, Redaelli M, C. Cho W, Kobarfard F, Rajabi S, Martorell M, Kumar P,
et al. Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules. 2019; 9(12):773.
https://doi.org/10.3390/biom9120773
Chicago/Turabian Style
Salehi, Bahare, Zeliha Selamoglu, Ksenija S. Mileski, Raffaele Pezzani, Marco Redaelli, William C. Cho, Farzad Kobarfard, Sadegh Rajabi, Miquel Martorell, Pradeep Kumar,
and et al. 2019. "Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine" Biomolecules 9, no. 12: 773.
https://doi.org/10.3390/biom9120773
APA Style
Salehi, B., Selamoglu, Z., S. Mileski, K., Pezzani, R., Redaelli, M., C. Cho, W., Kobarfard, F., Rajabi, S., Martorell, M., Kumar, P., Martins, N., Subhra Santra, T., & Sharifi-Rad, J.
(2019). Liposomal Cytarabine as Cancer Therapy: From Chemistry to Medicine. Biomolecules, 9(12), 773.
https://doi.org/10.3390/biom9120773